BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 3 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2024. The put-call ratio across all filers is - and the average weighting 5.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,009,000 | – | 23,053 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 749,815 | $19,315,000 | 19.83% |
| Foresite Capital Management IV, LLC | 851,200 | $21,927,000 | 9.09% |
| VHCP Management II, LLC | 1,390,391 | $35,816,000 | 8.64% |
| Vivo Capital, LLC | 2,049,545 | $52,796,000 | 7.48% |
| Ghost Tree Capital, LLC | 550,000 | $14,168,000 | 2.87% |
| Perceptive Advisors | 2,927,449 | $71,224,000 | 2.00% |
| EMORY UNIVERSITY | 88,462 | $2,279,000 | 1.63% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 515,737 | $13,285,000 | 1.05% |
| ARS Investment Partners, LLC | 260,255 | $6,704,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 869,000 | $22,385,000 | 0.78% |